THE USE OF KETOROLAC IN LUMBAR SPINE SURGERY - A COST-BENEFIT-ANALYSIS

被引：37
作者：
TURNER, DM [1 ]
WARSON, JS [1 ]
WIRT, TC [1 ]
SCALLEY, RD [1 ]
COCHRAN, RS [1 ]
MILLER, KJ [1 ]
机构：
[1] POUDRE VALLEY HOSP,FRONT RANGE CTR BRAIN,FT COLLINS,CO
来源：
JOURNAL OF SPINAL DISORDERS | 1995年 / 8卷 / 03期
关键词：
KETOROLAC; LUMBAR SPINE SURGERY; NARCOTIC USE; POSTOPERATIVE AMBULATION; COST SAVINGS;
D O I：
10.1097/00002517-199506000-00005
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The use of ketorolac was studied in patients undergoing lumbar laminectomy and those receiving lumbar fusion with or without instrumentation. Laminectomy patients in the ketorolac group used significantly less narcotic analgesic than did those in the narcotic treatment group. Ketorolac patients in both surgical categories experienced better pain control than narcotic group patients did. Laminectomy ketorolac patients experienced less sedation than did those in the narcotic group, and a similar trend was noted for fusion patients. A significant improvement in postoperative ambulation was demonstrated in the fusion ketorolac group. Postoperative total drug costs were significantly greater in both ketorolac treatment groups. A one-half day decrease in hospitalization was noted for laminectomy ketorolac patients. The overall annual financial impact of the use of ketorolac in lumbar spine patients is a net savings of $211,095.
引用
收藏
页码：206 / 212
页数：7
相关论文
共 11 条
  • [1] Baumann T.J., Batenhorst R.L., Graves D.A., Foster T.S., Bennett R.L., Patient-controlled analgesia in the terminally ill cancer patient, Drug Inlell Clin Pharm, 20, pp. 297-301, (1986)
  • [2] Bennett R., Batenhorst R., Graves D., Foster T.S., Baumann T., Griffen W.O., Wright B.D., Morphine titration in postoperative laparotomy patients using patient-controlled analgesia, Curr Ther Res, 32, pp. 45-52, (1982)
  • [3] Bennett R.L., Batenhorst R.L., Bivins B.A., Et al., Patient-controlled analgesia, Ann Surg, 6, pp. 700-704, (1982)
  • [4] Canadell-Carafi J., Moreno-Londono A., Gonzalez-Caudevilla B., Ketorolac, a new non-opioid analgesic: A single-blind trial versus buprenorphine in pain after orthopaedic surgery, Curr Medresopin, 12, pp. 343-348, (1991)
  • [5] Graves D.A., Batenhorst R.L., Bennett R.L., Wettstein J.G., Griffen W.O., Wright B.D., Foster T.S., Morphine requirements using patient-controlled analgesia: Influence of diurnal variation and morbid obesity, Clin Pharm, 2, pp. 49-53, (1983)
  • [6] Graves D.A., Baumann T.J., Batenhorst R.L., Foster T.S., The relative dose indicator: A novel tool for clinical narcotic research, Curr Ther Res, 4, pp. 751-759, (1984)
  • [7] Kinsella J., Moffat A.C., Patrick J.A., Prentice J.W., Mc Ardle C.S., Kenny G.N., Ketorolac trometamol for postoperative analgesia after orthopaedic surgery, Br J Anaesth, 69, pp. 19-22, (1992)
  • [8] Litvak K.M., Mc Evoy G.K., Ketorolac, an injectable nonnarcotic analgesic, Clin Pharm, 9, pp. 921-935, (1990)
  • [9] Resman-Targoff B.H., Ketorolac: A parenteral nonsteroidal an-tiinflammatory drug, Dicpann Pharmacother, 24, pp. 1098-1104, (1990)
  • [10] Scalley R.D., Berquist K.D., Cochran R.S., Patient-controlled analgesia in orthopedic procedures, Orthop Rev, 11, pp. 1106-1113, (1988)
12